Skip to content
Clinical Trial Events
DIA Europe

Talk CMC & Product Quality track

S0202 - Opportunities from Regulatory Reliance on Post-Approval CMC Changes and GMP Inspections

Wed, Mar 19, 2025 · 3:00–4:10 PM CET Kairo 1-2 Room, Congress Center Basel

About this session

The session will focus on the current status of reliance and recognition globally. We will discuss reducing PACs, transformation of LCM and emerging GMPs in the context of submissions and regulatory inspections.

Programme:
- 3. Opportunities for Convergence and Reliance for PACs — Isabelle Colmagne-Poulard
- 1. International collaborations to support Reliance — Brendan Cuddy
- 5. Emerging GMPs in the Context of Submissions and Regulatory Inspections — Stephan Roenninger
- Panel Discussion — Marie Valentin, Günter Waxenecker
- 2. Europe at the Cutting Edge: The Transformation of Lifecycle Management — Monica Perea-Velez
- 0. Setting the Scene — Evdokia  Korakianiti
- 4. A Practical Approach to Post Approval Change Processes to Mitigate Shortage Risks to Global Supplies — Angelika Joos

Speakers

  • Evdokia  Korakianiti

    Head of Quality and Safety of Medicines · European Medicines Agency

    Chair

  • Günter Waxenecker

    Head of the Austrian Medicines and Medical Devices Agency · Austrian Medicines and Medical Devices Agency (AGES)

    Panelist

  • Marie Valentin

    Lead, Special Access Programme · World Health Organization (WHO)

    Panelist

  • Brendan Cuddy

    Lead Scientific Officer · European Medicines Agency

    Speaker

  • Angelika Joos

    Independent consultant · CRP International Strategy Consulting

    Speaker

  • Isabelle Colmagne-Poulard

    Head of International Global Regulatory & Scientific Policy · Merck KGaA

    Speaker

  • Monica Perea-Velez

    CMC Advocacy and Policy Director · GSK

    Speaker

  • Stephan Roenninger

    Director Quality Compliance External Affairs · Amgen (Europe) GmbH

    Speaker

  • Amanda Tombs

    Regulatory Affairs Director · AstraZeneca

    Chair